Connect with us

Technology

Hospital PMI® at 55.8%; June 2024 Hospital ISM® Report On Business®

Published

on

TEMPE, Ariz., July 5, 2024 /PRNewswire/ — Economic activity in the hospital subsector grew in June for the 10th consecutive month after contracting twice in the previous four-month period, with 35 consecutive months of growth prior to that, say the nation’s hospital supply executives in the latest Hospital ISM® Report On Business®.

The report was issued today by Nancy LeMaster, MBA, Chair of the Institute for Supply Management® (ISM®) Hospital Business Survey Committee: “The Hospital PMI® registered 55.8 percent in June, a 2.6-percentage point decrease from the May reading of 58.4 percent, indicating a 10th consecutive month of growth after a contraction in August. The Business Activity Index expanded for the 10th consecutive month. The New Orders Index expanded for the 10th straight month, and the Employment Index remained in growth territory. The Supplier Deliveries Index remained in expansion (which indicates slower delivery performance). The Case Mix Index expanded in June, registering 51 percent, a decrease of 0.5 percentage point compared to the previous month’s figure of 51.5 percent. The Days Payable Outstanding Index remained in expansion territory in June, registering 51.5 percent, down 5.5 percentage points from the 57 percent reported in May. The Technology Spend Index reading of 61.5 percent is an increase of 1 percentage point compared to the 60.5 percent recorded in May. The Touchless Orders Index was ‘unchanged’ in June, registering 50 percent, up 1.5 percentage points from the 48.5 percent reported in May.”

LeMaster continues, “The majority of Business Survey Committee respondents indicated that patient volumes in June were strong — just not as strong as in May. Some panelists commented that their facilities experienced a shift to more medical versus surgical patients, while others noted elevated levels of surgeries and outpatient volumes. The Employment Index continued to indicate growth, with respondents crediting successful recruitment efforts and a reduction in turnover. To preserve margins, hospitals continued to focus on (1) replacing agency labor with permanent staff to reduce labor costs and (2) reducing utilization and increasing standardization of supplies. Weather impacted supply deliveries in parts of the country, and the syringe shortage continues to be problematic.”

Hospital PMI® History

Month

Hospital PMI®

Month

Hospital PMI®

Jun 2024

55.8

Dec 2023

62.5

May 2024

58.4

Nov 2023

59.8

Apr 2024

53.5

Oct 2023

52.1

Mar 2024

52.3

Sep 2023

57.0

Feb 2024

56.6

Aug 2023

47.5

Jan 2024

61.5

Jul 2023

53.3

Average for 12 months – 55.9

High – 62.5

Low – 47.5

 

About This Report
The information compiled in this report is for the month of June 2024.

The Hospital PMI® was developed in collaboration with the Association for Health Care Resource & Materials Management (AHRMM), an association for the health care supply chain profession, and a professional membership group of the American Hospital Association (AHA).

The data presented herein is obtained from a survey of hospital supply executives based on information they have collected within their respective organizations. ISM® makes no representation, other than that stated within this release, regarding the individual company data collection procedures. The data should be compared to all other economic data sources when used in decision-making.

Data and Method of Presentation
The Hospital ISM® Report On Business® is based on data compiled from hospital purchasing and supply executives nationwide. Survey responses reflect the change, if any, in the current month compared to the previous month. For each of the indicators measured (Business Activity, New Orders, Employment, Supplier Deliveries, Inventories, Prices, Prices: Pharmaceuticals, Prices: Supplies, Backlog of Orders, Imports, Inventory Sentiment, Case Mix, Days Payable Outstanding, Technology Spend, and Touchless Orders), this report shows the percentage reporting each response and the diffusion index. Responses represent raw data and are never changed. Beginning in January 2021, the Report On Business® staff and consultants are gathering market information to better validate the Exports Index. Exports Index data are still being collected.

The Hospital PMI® is a composite index computed from the following, equally weighted indexes: Business Activity, New Orders, Employment and Supplier Deliveries. Diffusion indexes have the properties of leading indicators and are convenient summary measures showing the prevailing direction of change and the scope of change. A Hospital PMI® index reading above 50 percent indicates that the hospital sub-sector is generally expanding; below 50 percent indicates that it is generally declining. For the sub-indexes, except Supplier Deliveries, an index reading above 50 percent indicates that the sub-index is generally expanding; below 50 percent indicates that it is generally contracting. A Supplier Deliveries Index above 50 percent indicates slower deliveries and below 50 percent indicates faster deliveries.

The Hospital ISM® Report On Business® survey is sent out to the Hospital Business Survey Committee respondents the first part of each month. Respondents are asked to ONLY report on U.S. operations for the current month. ISM® receives survey responses throughout most of any given month, with the majority of respondents generally waiting until late in the month to submit responses to give the most accurate picture of current business activity. ISM® then compiles the report for release on the fifth business day of the following month.

ISM ROB Content
The Institute for Supply Management® (“ISM”) Report On Business® (Manufacturing, Services, and Hospital reports) (“ISM ROB”) contains information, text, files, images, video, sounds, musical works, works of authorship, applications, and any other materials or content (collectively, “Content”) of ISM (“ISM ROB Content”). ISM ROB Content is protected by copyright, trademark, trade secret, and other laws, and as between you and ISM, ISM owns and retains all rights in the ISM ROB Content. ISM hereby grants you a limited, revocable, nonsublicensable license to access and display on your individual device the ISM ROB Content (excluding any software code) solely for your personal, non-commercial use. The ISM ROB Content shall also contain Content of users and other ISM licensors. Except as provided herein or as explicitly allowed in writing by ISM, you shall not copy, download, stream, capture, reproduce, duplicate, archive, upload, modify, translate, publish, broadcast, transmit, retransmit, distribute, perform, display, sell, or otherwise use any ISM ROB Content.

Except as explicitly and expressly permitted by ISM, you are strictly prohibited from creating works or materials (including, but not limited to tables, charts, data streams, time-series variables, fonts, icons, link buttons, wallpaper, desktop themes, online postcards, montages, mashups and similar videos, greeting cards, and unlicensed merchandise) that derive from or are based on the ISM ROB Content. This prohibition applies regardless of whether the derivative works or materials are sold, bartered, or given away. You shall not either directly or through the use of any device, software, internet site, web-based service, or other means remove, alter, bypass, avoid, interfere with, or circumvent any copyright, trademark, or other proprietary notices marked on the Content or any digital rights management mechanism, device, or other content protection or access control measure associated with the Content including geo-filtering mechanisms. Without prior written authorization from ISM, you shall not build a business utilizing the Content, whether or not for profit.

You shall not create, recreate, distribute, incorporate in other work, or advertise an index of any portion of the Content unless you receive prior written authorization from ISM. Requests for permission to reproduce or distribute ISM ROB Content can be made by contacting Rose Marie Goupil in writing at: ISM Research, Institute for Supply Management, 309 W. Elliot Road, Suite 113, Tempe, AZ 85284-1556, or by emailing rgoupil@ismworld.org; Subject: Content Request.

ISM shall not have any liability, duty, or obligation for or relating to the ISM ROB Content or other information contained herein, any errors, inaccuracies, omissions or delays in providing any ISM ROB Content, or for any actions taken in reliance thereon. In no event shall ISM be liable for any special, incidental, or consequential damages, arising out of the use of the ISM ROB. Report On Business®, PMI®, Manufacturing PMI®, Services PMI®, and Hospital PMI® are registered trademarks and trademarks of Institute for Supply Management®. Institute for Supply Management® and ISM® are registered trademarks of Institute for Supply Management, Inc.

About Institute for Supply Management®
Institute for Supply Management® (ISM®) is the first and leading not-for-profit professional supply management organization worldwide. Its community of more than 50,000 in more than 100 countries manage about US$1 trillion in corporate and government supply chain procurement annually. Founded in 1915 by practitioners, ISM is committed to advancing the practice of supply management to drive value and competitive advantage for its members, contributing to a prosperous and sustainable world. ISM empowers and leads the profession through the ISM® Report On Business®, its highly-regarded certification and training programs, corporate services, events, and assessments. The ISM® Report On Business®, Manufacturing, Services, and Hospital, are three of the most reliable economic indicators available, providing guidance to supply management professionals, economists, analysts, and government and business leaders. For more information, please visit: www.ismworld.org.

The text version of the public Hospital ISM® Report On Business® is posted on ISM®’s website at www.ismrob.org on the fifth business day* of every month at 10:00 a.m. ET.

The next Hospital ISM® Report On Business® featuring July 2024 data will be released at 10:00 a.m. ET on Wednesday, August 7, 2024.

*Unless the New York Stock Exchange is closed.

Contact: 

Rose Marie Goupil

Report On Business® Analyst

ISM®, ROB/Program Manager

Tempe, Arizona

+1 480.752.6276, ext. 3005

Email: rgoupil@ismworld.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/hospital-pmi-at-55-8-june-2024-hospital-ism-report-on-business-302189179.html

SOURCE Institute for Supply Management

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Summit of Whose Future? Girls Have the Answers: Leaders Must Listen

Published

on

By

Young Women Activists Launch “What Girls Want,” Demand World Leaders Put Girls at the Center of Summit of the Future 

NEW YORK, Sept. 21, 2024 /PRNewswire/ — Today in New York, more than 50 young women from around the world – including Nobel Prize Laureate Malala Yousafzai – gathered to take government to task for failing to prioritize girls and young women in the upcoming Summit of the Future. The group is backed by acoalition of girl-centered non-profit organizations, institutions, and funds who synthesized the demands of girls at www.whatgirlswant.com.

At a demonstration near the UN, alongside life-size cutouts of world leaders dressed ironically as “girl experts”, the activists delivered a strong message: world leaders aren’t the experts on what girls want for their futures – girls are. 

Eylül Erçin, 19, from Türkiye, shared: “The time has passed for girls and young women to be treated as mere afterthoughts. Leaders must include us in the foundational design of these processes, ensuring that our priorities are integrated into shaping the future we will inherit. Anything less is unacceptable.”

Today’s event is about more than calling out a process failure. Girls i from around the world delivered a forward-looking call to action this week. They expect governments, institutions, and community leaders to step up and help shape a more equitable future.

Alongside fellow activists, Malala said: “Even at 27, I know better than to assume I understand best what girls want. Everywhere I go, girls are eager to share their vision for their futures. As adults, it is our job to listen, fund their work and follow their lead. It is not too late for world leaders to do right by girls. They can start by prioritizing their demands in tomorrow’s final Summit deliberations and by investing resources to match their words.”

The evidence is clear: investing in girls and delivering on their rights transforms economies, societies, and the environment, advancing the SDGs and building a future that girls deserve.

About What Girls Want 

This effort was produced by a collaboration of girl-centered organizations, institutions, funders, and allies. The campaign is anchored around work to collate insights, data, and stories from 20+ public consultations with girls and young women over the past decade, driven by a shared desire to center girls’ demands in spaces where they are being ignored. 

Contact:

whatgirlswantpress@gmail.com

nate.powers@edelman.com

Logo – https://mma.prnewswire.com/media/2384993/Women_Deliver_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/summit-of-whose-future-girls-have-the-answers-leaders-must-listen-302254570.html

Continue Reading

Technology

48-Hour Saudi Visa Processing, Major Discounts and Unmissable Giveaways – Only at ‘Spectacular Saudi’ in Mumbai

Published

on

By

NEW DELHI, Sept. 21, 2024 /PRNewswire/ — Saudi’s national tourism brand, ‘Saudi Welcome to Arabia’ is hosting its first-ever immersive consumer event ‘Spectacular Saudi’, from September 25 to October 2,  from 2:00 p.m. – 10:30 p.m. at R2 Ground in BKC, Mumbai.

Slated to transport visitors straight to the Heart of Arabia; the 8-day immersive experience will give visitors a glimpse into Saudi’s many wonders and iconic experiences – all while extending the warm Saudi welcome. To give consumers a truly memorable experience Saudi is offering exclusive giveaways and discounts specially curated for Indian travellers.

What’s more, Indian travellers can fast-track their Saudi visas exclusively at the event. All you need is a valid Visa or Mastercard credit card! Head on over to one of eight dedicated Tasheer kiosks, ensure the name on the credit card matches the passport, and have sufficient funds available on the card. After that, sit back and relax as your visa will be in hand within 48 hours!

It has never been easier to visit Saudi. With the most seamless visa process offered to date, the excitement doesn’t end there. On the travel front, SAUDIA Airlines is offering special deals, including a buy one get 50% off on the second ticket if travelling business class. Additionally, all economy class tickets will be 15% off. Attendees will also have the chance to participate in daily giveaways for free flight tickets for two to Saudi. With over 50+ travel trade offers, visitors can access incredible cashback and discounts on Saudi travel packages. Additionally, those booking Saudi packages will enjoy complimentary cultural city tours. Group tour packages to Riyadh, Jeddah, and Dammam will be available exclusively at the event, starting at INR 99,999 for 5 nights.

Visitors can expect unique immersive experiences–including exhibits, culinary delights, Ardah dancers, Saudi coffee, traditional scents, and fashion–all under one roof. So don’t miss out and register here to experience a piece of Saudi, right in the heart of Mumbai.

Photo – https://mma.prnewswire.com/media/2511104/Spectacular_Saudi.jpg

 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/48-hour-saudi-visa-processing-major-discounts-and-unmissable-giveaways–only-at-spectacular-saudi-in-mumbai-302254776.html

Continue Reading

Technology

Indian Cancer Genome Atlas Launches the Country’s First Comprehensive Cancer Multi-Omics Data Portal

Published

on

By

Offers open access to cancer data for research

NEW DELHI, Sept. 21, 2024 /PRNewswire/ — The Indian Cancer Genome Atlas (ICGA) has launched India’s first comprehensive cancer multi-omics data portal. This pioneering platform provides open access to clinically correlated data from Indian cancer patients, aimed at transforming cancer research and treatment for Indian populations.

Historically, cancer treatments in India have been based on Western data sets. However, cancers in Indian patients can differ significantly at the molecular level. ICGA’s mission is to create Indian-specific datasets to help researchers and clinicians develop personalized treatment protocols. This new open-access portal represents a monumental step in revolutionizing cancer research, specifically for Indian patients.

The ICGA cancer multi-omics portal is the first in India to offer data that includes DNA, RNA, and protein profiles of breast cancer patients, integrated with clinical outcomes. Currently, the platform consists of data from 50 breast cancer patients, with plans to expand to over 500 patients in the coming year. This data is freely accessible to the global research community under India’s PRIDE guidelines, which promote ethical sharing and collaboration in cancer research.

Key Highlights of this portal include:

India’s First Cancer Multi-Omics Data Portal: A comprehensive resource that offers detailed multi-omics data for breast cancer patients, including genomic and proteomic information.Based on cBioPortal Platform: Derived from the internationally recognized cBioPortal, this platform ensures seamless integration with global cancer research efforts.Initial Dataset from 50 Indian Patients: Provides clinically annotated DNA, RNA, and protein profiles, along with treatment histories and patient outcomes, with an aim to scale up to 500 in a year.Free Access Under PRIDE Guidelines: Adhering to responsible and ethical data-sharing practices, the portal is freely accessible to the scientific community.A Step Toward Precision Oncology for Indian Patients: This initiative is designed to enable the development of personalized cancer treatments tailored to Indian patients.Call for Collaboration:  ICGA invites researchers worldwide to contribute and expand the platform, fostering global collaboration in cancer research.

Professor Shekhar C. Mande, Former DG-CSIR, Currently Senior Professor at Savitribai Phule Pune University
“Making this invaluable cancer data publicly accessible marks a pivotal step in accelerating scientific discoveries and enhancing patient outcomes. By openly sharing this data, we are empowering researchers, clinicians, and innovators to collaborate, explore new frontiers, and drive transformative breakthroughs in cancer treatment.”

Joint Statement from Dr JC Zenklusen – Director of The Cancer Genome Atlas (TCGA) at the NCI, NIH, USA, and Prof Sunil Badve – Vice Chair, Pathology Cancer Programs, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
“Fifteen years ago, when we launched TCGA, we could not have foreseen the remarkable progress cancer research would make. It is incredibly exciting to see ICGA advancing so rapidly and taking bold steps in revolutionizing cancer research. Understanding the genome of cancer patients will improve the treatment of Indians not only in India but also worldwide. We, both, encourage others with similar data to actively contribute to ICGA, so this initiative can grow even faster and drive greater breakthroughs.”

Dr. Anand Deshpande, Chairman and Managing Director at Persistent, and Non-Executive Director at ICGA
“We have made an excellent start with this groundbreaking multi-omics cancer portal. Cancer touches all of us, and the need for more effective, personalized treatments—especially tailored to the unique genetic and environmental factors in India—is urgent. This portal will empower researchers with crucial data to advance customized cancer research for better treatment outcomes. I encourage everyone to contribute and support this vital cause, helping us accelerate progress in the fight against cancer.”

About Indian Cancer Genome Atlas (ICGA):
The Indian Cancer Genome Atlas (ICGA) is a national initiative focused on mapping the genomic, transcriptomic, and proteomic landscapes of cancers across India. As a section 8 not-for-profit organization, the ICGA Foundation, operates through a public-private-philanthropic partnership, with active support from over 50 clinicians, researchers, and data analysts. Its mission is to enhance cancer diagnosis and treatment for Indian patients and contribute to the global understanding of cancer biology. The foundation’s first project focuses on the multi-omics profiling of breast cancer, with plans to extend this effort to other types of cancer in the future.

https://www.icga.in/

View original content:https://www.prnewswire.com/in/news-releases/indian-cancer-genome-atlas-launches-the-countrys-first-comprehensive-cancer-multi-omics-data-portal-302254777.html

Continue Reading

Trending